BioSpace News Archive

Business

Ambys Medicines Debuts in Unusual Deal with Takeda Pharmaceutical

Ambys Medicines, based in Redwood City, California, has launched in an unusual deal with Osaka, Japan’s Takeda Pharmaceutical Company.

August 8, 2018
·
2 min read
·
Mark Terry
Drug Development

Novo Nordisk U.S. Sales Slump in 2Q and Predicts Continued Decline for 2019

Shares of Novo Nordisk are down about five percent this morning after the company reported an overall decline in sales during the second quarter of this year. Sales were particularly disappointing in North America.

August 8, 2018
·
2 min read
·
Alex Keown
Business

Updated: Boston Scientific Continues M&A Spree with $160 Million Deal for Veniti; Lays Off 85 in Massachusetts

Two days after Boston Scientific laid off 85 employees at a Burlington, Mass. manufacturing site, the company forked over up to $160 million to acquire California stent maker Veniti, Inc. The deal marks the third acquisition for Boston Scientific in two months.

August 8, 2018
·
3 min read
·
Alex Keown
Genetown

SQZ Biotechnologies Closes Oversubscribed $72 Million Series C

Watertown, Massachusetts-based SQZ Biotechnologies completed an oversubscribed Series C financing worth $72 million. New investors included Everblue, Illumina Ventures, Invus, Orient Life, and Viva Ventures Biotech Group.

August 8, 2018
·
2 min read
·
Mark Terry
Policy

U.S. Rep. Chris Collins, an Innate Immunotherapeutics Board Member, Charged With Insider Trading

A New York Republican Congressman and his son have been charged with insider trading. U.S. Rep. Chris Collins was a board member for Australia-based Innate Immunotherapeutics. The government charged he used that information to help his son make timely trades.

August 8, 2018
·
2 min read
·
Alex Keown
Business

Pharma Companies Create Memorable Ad Campaigns for Branded Products

The pharma industry has developed ad campaigns to tout the efficacy of its branded products to consumers, often using celebrities to add his or her personal stamp onto a pharmaceutical product.

August 8, 2018
·
3 min read
·
Alex Keown
Business

Samsung Group to Invest $22 Billion in AI, 5G Mobile Tech, and Biopharma

As its core semiconductor and smartphone businesses slow down, South Korea’s Samsung Group has announced a broad investment into new areas. Those areas include artificial intelligence (AI), 5G mobile technology, electronic components for the automotive industry, and biopharmaceuticals.

August 8, 2018
·
3 min read
·
Mark Terry
Drug Development

Alnylam Adds Office Space, Employees Ahead of Aug. 11 PDUFA Date for Patisiran

After a slight delay, things remain on schedule for Alnylam’s new $200 million manufacturing facility. The company expects the site to open in late 2019, which could follow regulatory approval of patisiran, its RNAi treatment for Hereditary ATTR Amyloidosis.

August 8, 2018
·
2 min read
·
Alex Keown
BioCapital

A Roundup of Biopharma Companies that Announced Hiring Trends So Far this Year

Here’s a roundup of biopharma companies that have announced hiring trends since the beginning of the year.

August 8, 2018
·
6 min read
·
Mark Terry
Business

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2018 Results Presentation and Webcast

Nordic Nanovector ASA announces its second quarter and first half 2018 results on Wednesday, 22 August 2018.

August 8, 2018
·
2 min read